it is marketed as co-danthrusate (when combined with docusate) and co-danthramer (when combined with poloxamer '188')
danthron is genotoxic and has been shown to be carcinogenic in rodent studies
the Committee on Safety on Medicines (CSM) has advised that the use of danthron-containing products be restricted to constipation in the terminally ill patients of all ages
Reference:
Current Problems in Pharmacovigilance (2000), 26, 4.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.